Importantly, it remains to be determined whether SNHG5 can regulate the expression or activity of GNB2—either directly or indirectly—to co-drive metastatic phenotypes such as enhanced migration, invasion, survival, and immune evasion in CRC cells. The gene discussed is GNB2; the disease is colorectal carcinoma.